Bixiye
P37-20 Coronavirus (COVID-19) Information for Providers
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2020
Natiijooyinka Raadinta
Soo bandhiga 2181 - 2190 ee natiijooyinka 4296
Bixiye
P36-20 Clinical Laboratory Improvement Amendments (CLIA) Requirements Enforcement
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2020
Bixiye
P30-20 2020 Renewal Changes Summary for Aware Professional Providers
Taariikhda uu dhaqangalayo Barnaamijka: May 01, 2020
Bixiye
QP87-19 Medical Drug Exclusion Lists Expanded to Include Triluron – Commercial Products
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
QP86-19 Pharmacy Benefit Exclusion for Invermectin Cream 1%
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
QP90-19 Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: tadalafil
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
QP89-19 CMS Provider Data Accuracy Audit
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
QP92-19 Multiple Claim Appeals for Minnesota Health Care Programs (MHCP)
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
QP91-19 Availity Provider Portal Authorization Tool Enhancements
Taariikhda uu dhaqangalayo Barnaamijka: Nov 13, 2019
Bixiye
P23R1-19 Alignment of Start Date for Prior Authorization Requests
Taariikhda uu dhaqangalayo barnaamijka: Okt 01, 2019